Best Grants for HIV / AIDS in Arizona

Research institutions and investigators conducting HIV clinical trials for pediatric, adolescent, young adult, and maternal populations, including those in Arizona, can apply for up to US $30,000,000 from the National Institutes of Health. Funding supports rigorously designed, collaborative trials addressing high-priority HIV research, related comorbidities, and coinfections across designated U.S. jurisdictions.

Arizona research institutions and multidisciplinary teams working on HIV and hepatitis B can access funding through the National Institutes of Health for observational cohorts and related translational research. Grants up to US $8,000,000 support studies on HBV persistence and pathogenesis, biomarker discovery, new drug targets, and non-invasive diagnostics using existing clinical data and samples.

Students and recent graduates planning unpaid summer 2025 internships in HIV/AIDS research, advocacy, or services at U.S.-accredited institutions may be eligible for funding up to Up to US $7,000. Point Foundation supports LGBTQ+ and ally scholars, and Arizona-based applicants working on HIV/AIDS issues can use this to make vital internships financially feasible.

Research institutions conducting HIV/AIDS implementation science in Arizona and across the U.S. can seek funding to build and sustain multidisciplinary Centers for AIDS Research. With a mission to advance HIV/AIDS research infrastructure, US Dept. of Health & Human Services: National Institutes of Health provides support for collaborations, core facilities, and pilot studies that accelerate treatment, prevention, and cure strategies.

Research institutions and multidisciplinary scientific teams studying HIV and other infectious diseases in Arizona can access funding through the National Institutes of Health to establish structural biology centers. These centers will determine 3D structures of key biomolecules, advance structural biology technologies, and support structure-guided design of new diagnostics and treatments.

Research institutions and other eligible organizations conducting substance use and HIV prevention or services research in Arizona and nationwide can access funding through the National Institutes of Health. This program supports pilot and feasibility studies to develop or adapt interventions, test acceptability and feasibility, and create measures or methods for future trials involving substance use and HIV.

Arizona researchers and institutions focused on HIV prevention and treatment can pursue funding for pioneering studies on HIV-related chronic conditions, coinfections, and comorbidities. US Dept. of Health & Human Services: National Institutes of Health supports early-career investigators, including those in mathematics, engineering, computer science, and AI, especially addressing pediatric and maternal HIV populations.

Arizona HIV / AIDS researchers and institutions can access funding through the US Dept. of Health & Human Services: National Institutes of Health for biphasic R21/R33 studies on HIV immunotherapies and central nervous system outcomes. Projects should evaluate mechanisms, benefits, and risks, aiming to improve neurologic and cognitive outcomes and inform strategies for sustained virologic remission.

Arizona HIV/AIDS research institutions and clinical organizations can access funding through National Institutes of Health to serve as Clinical Trials Units within HIV/AIDS Clinical Trials Networks. Awards support randomized clinical studies and implementation research on HIV prevention and treatment, including domestic and international clinical research sites coordinated through an administrative hub.

Research institutions and data centers working on HIV/AIDS clinical trials in Arizona and nationwide can seek funding to serve as Statistical and Data Management Centers, supporting NIH HIV Clinical Trials Networks. With a mission to advance HIV prevention, treatment, and implementation research, NIH provides support to lead study design, data management, monitoring, and analysis.

Research institutions and clinical laboratories in Arizona and other eligible U.S. locations can seek funding to serve as Laboratory Centers supporting HIV/AIDS clinical trials networks. US Dept. of Health & Human Services: National Institutes of Health provides resources to manage trial-related laboratory testing, data systems, assay development, and expanded testing capacity for HIV prevention and treatment studies.

Research institutions and clinical trial networks working on HIV/AIDS prevention, treatment, and implementation research in Arizona can apply for NIH support to lead a Clinical Trials Network Leadership and Operations Center. US Dept. of Health & Human Services: National Institutes of Health funding supports LOCs focused on therapeutics, biomedical prevention, immune-based strategies, and maternal, adolescent, and pediatric HIV care.

Public health agencies and research organizations in Arizona and other U.S. jurisdictions can apply for Centers for Disease Control and Prevention support to conduct ongoing HIV behavioral and bio-behavioral surveillance. Funding supports data collection on risk behaviors, testing, and prevention service use to inform and improve HIV prevention programs and services over time.

Research institutions conducting substance use, addiction, and HIV studies in Arizona and nationwide can access funding to build a Core Center of Transformative Science. Arizona HIV/AIDS and addiction research programs can apply through the National Institutes of Health to create shared resources, support interdisciplinary collaborations, and expand opportunities for early-career investigators.

Research institutions and organizations conducting HIV/AIDS research in Arizona and other eligible U.S. locations can apply for US $212,004 - US $2,725,311 to develop and manage specific pathogen free in vivo models and human new approach methodologies. Funding from National Institutes of Health supports NAMs-enabled stewardship frameworks, in vitro testing support, and high-quality SPF colony resources.

Arizona research institutions and partners focused on HIV/AIDS mental health research can access funding through the National Institutes of Health to establish or expand AIDS Research Centers. These centers advance interdisciplinary HIV/AIDS science, foster collaboration, and support work across basic, clinical, behavioral, implementation, and data science domains in line with national HIV research strategies.

The Ryan White HIV/AIDS Program (RWHAP) Integrated HIV/AIDS Planning Resource Allocation Cooperative Agreement aims to enhance the effectiveness of HIV prevention and care planning for RWHAP Parts A and B recipients. Through the provision of training, tools, and technical assistance, this initiative seeks to optimize resource allocation and strengthen the overall system of HIV care and treatment, ultimately improving health outcomes for those affected by HIV.

The AIDS Drug Assistance Program (ADAP) Emergency Relief Funds aim to provide essential funding to states and territories. This initiative focuses on preventing, reducing, or eliminating waiting lists for ADAP services, ensuring timely access to necessary medications and support for individuals living with HIV/AIDS. This program addresses critical funding shortfalls, enhancing the healthcare infrastructure and improving health outcomes in affected communities.

The Ryan White HIV/AIDS Program Part C Capacity Development Program aims to enhance the capabilities of community-based organizations, focusing on improving health outcomes and decreasing HIV transmission. This initiative supports individuals who have not yet accessed regular HIV care, emphasizing innovative care solutions and infrastructure development to address these critical needs.

The HIV Care Grant Program, funded by the US HHS: Health Resources & Services Administration (HRSA), aims to enhance access to high-quality HIV care and treatment for low-income individuals. This initiative supports states and territories in developing comprehensive systems to address the needs of those living with HIV. By providing essential resources, the program seeks to improve health outcomes and ensure that vulnerable populations receive the necessary support and services.

The Ryan White HIV/AIDS Program Part B Supplemental Grant aims to provide essential funding to support HIV care and treatment services across states and territories. This program supplements existing formula-based funding from the RWHAP Part B and ADAP, improving access to necessary resources for those affected by HIV/AIDS. By enhancing support structures, it addresses critical healthcare needs, ensuring better health outcomes for vulnerable populations.

The HIV Care Grant Program aims to enhance access to comprehensive, high-quality HIV care and treatment for low-income individuals in Pacific Island territories. Funded by the US HHS: Health Resources & Services Administration (HRSA), this initiative supports states and territories in developing effective systems of care, ensuring that those affected by HIV receive the necessary treatment and support to improve health outcomes.

This funding opportunity aims to enhance a web-based ordering portal for distributing 1.5 million HIV and STI self-tests to high-burden communities. By optimizing access to these self-tests, the initiative seeks to raise awareness, prevent new infections, and improve the health outcomes of users, thereby contributing to better overall public health and wellbeing.

The Ittleson Foundation, established in 1932, focuses on enhancing mental health, AIDS prevention, and environmental initiatives. It funds not-for-profit organizations aiming to improve public policy and the lives of citizens. The Foundation is particularly interested in innovative projects addressing mental health stigma, advancing preventative efforts, and supporting underserved populations. While it funds new initiatives, it does not typically support capital projects, endowments, or direct service programs outside New York City.

Bristol Myers Squibb is dedicated to enhancing healthcare and advancing scientific knowledge through its Corporate Giving program. By supporting various organizations, BMS aims to improve health equity and access to essential medicines for underserved populations. Their focus includes charitable donations, medical education, and community support initiatives. This commitment reflects BMS's goal to make a positive impact on patients' lives and foster strong communities where their employees work and live.

Nonprofit organizations providing HIV/AIDS direct care, prevention, or education services in Arizona can seek one-year project support, with awards up to US $25,000. The Elizabeth Taylor AIDS Foundation prioritizes agencies with at least three years of HIV/AIDS program experience; some proposals, including many direct service projects, are considered by invitation only.